P247 Safety profile of the duodenal-jejunal bypass liner (endobarrier): a multicentre randomised control trial
IntroductionThe Endobarrier is an endoluminal duodenal-jejunal bypass liner (DJBL) developed by GI Dynamics for the treatment of obese patients with T2DM. It consists of a single use endoscopic implant designed to mimic the effects of gastric bypass but without the risks of undergoing surgery and th...
Saved in:
Published in | Gut Vol. 70; no. Suppl 1; p. A170 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group LTD
01.01.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | IntroductionThe Endobarrier is an endoluminal duodenal-jejunal bypass liner (DJBL) developed by GI Dynamics for the treatment of obese patients with T2DM. It consists of a single use endoscopic implant designed to mimic the effects of gastric bypass but without the risks of undergoing surgery and the possible long-term complications associated with bariatric surgery. We report results of its safety profile in patients receiving the device for one-year duration of therapy as part of the Endobarrier randomised controlled trial (RCT).MethodsThe multicentre Endobarrier RCT (NCT02459561) was conducted across two sites in the UK and recruited 170 patients with Type 2 Diabetes and BMI 30–50 kg/m2. Participants were randomised to receive the DJBL (n=85) for one year or conventional medical therapy, diet and exercise (n=85).ResultsA total of 75/85 participants received the Endobarrier implant. There were 19 (25%) early explants (table 1) before the one year period for which the commonest indication for removal was abdominal pain and device migration. There were two GI bleeds and one liver abscess which was managed with antibiotics and drainage with no permanent sequelae.Abstract P247 Table 1 Early Explants Frequency Upper GI Bleeds 2 Abdominal pain 5 Cholestasis/cholecystitis 2 Migration and fistula 1 Migrations 6 Liver abscess 1 Required anticoagulation 1 Withdrew consent 1 Total 19 ConclusionsThe majority of patients received one year of Endobarrier therapy. The early explant rate of 25% is in keeping with previously conducted clinical trials on the Endobarrier. There was one case of liver abscess in the 75 successful implants performed - a complication rate of 1.3% which is similar to post market surveillance data (1%) from GI Dynamics. Liver abscesses still remain a rare but significant complication of Endobarrier therapy. |
---|---|
AbstractList | IntroductionThe Endobarrier is an endoluminal duodenal-jejunal bypass liner (DJBL) developed by GI Dynamics for the treatment of obese patients with T2DM. It consists of a single use endoscopic implant designed to mimic the effects of gastric bypass but without the risks of undergoing surgery and the possible long-term complications associated with bariatric surgery. We report results of its safety profile in patients receiving the device for one-year duration of therapy as part of the Endobarrier randomised controlled trial (RCT).MethodsThe multicentre Endobarrier RCT (NCT02459561) was conducted across two sites in the UK and recruited 170 patients with Type 2 Diabetes and BMI 30–50 kg/m2. Participants were randomised to receive the DJBL (n=85) for one year or conventional medical therapy, diet and exercise (n=85).ResultsA total of 75/85 participants received the Endobarrier implant. There were 19 (25%) early explants (table 1) before the one year period for which the commonest indication for removal was abdominal pain and device migration. There were two GI bleeds and one liver abscess which was managed with antibiotics and drainage with no permanent sequelae.Abstract P247 Table 1Early Explants Frequency Upper GI Bleeds 2 Abdominal pain 5 Cholestasis/cholecystitis 2 Migration and fistula 1 Migrations 6 Liver abscess 1 Required anticoagulation 1 Withdrew consent 1 Total 19 ConclusionsThe majority of patients received one year of Endobarrier therapy. The early explant rate of 25% is in keeping with previously conducted clinical trials on the Endobarrier. There was one case of liver abscess in the 75 successful implants performed - a complication rate of 1.3% which is similar to post market surveillance data (1%) from GI Dynamics. Liver abscesses still remain a rare but significant complication of Endobarrier therapy. IntroductionThe Endobarrier is an endoluminal duodenal-jejunal bypass liner (DJBL) developed by GI Dynamics for the treatment of obese patients with T2DM. It consists of a single use endoscopic implant designed to mimic the effects of gastric bypass but without the risks of undergoing surgery and the possible long-term complications associated with bariatric surgery. We report results of its safety profile in patients receiving the device for one-year duration of therapy as part of the Endobarrier randomised controlled trial (RCT).MethodsThe multicentre Endobarrier RCT (NCT02459561) was conducted across two sites in the UK and recruited 170 patients with Type 2 Diabetes and BMI 30–50 kg/m2. Participants were randomised to receive the DJBL (n=85) for one year or conventional medical therapy, diet and exercise (n=85).ResultsA total of 75/85 participants received the Endobarrier implant. There were 19 (25%) early explants (table 1) before the one year period for which the commonest indication for removal was abdominal pain and device migration. There were two GI bleeds and one liver abscess which was managed with antibiotics and drainage with no permanent sequelae.Abstract P247 Table 1 Early Explants Frequency Upper GI Bleeds 2 Abdominal pain 5 Cholestasis/cholecystitis 2 Migration and fistula 1 Migrations 6 Liver abscess 1 Required anticoagulation 1 Withdrew consent 1 Total 19 ConclusionsThe majority of patients received one year of Endobarrier therapy. The early explant rate of 25% is in keeping with previously conducted clinical trials on the Endobarrier. There was one case of liver abscess in the 75 successful implants performed - a complication rate of 1.3% which is similar to post market surveillance data (1%) from GI Dynamics. Liver abscesses still remain a rare but significant complication of Endobarrier therapy. |
Author | Prechtl, Christina Al-Najim, Werd Ruban, Aruchuna Aldhwayan, Madhawi Glaysher, Michael Goldstone, Anthony Chhina, Navpreet Teare, Julian Byrne, James Miras, Alexander Ashrafian, Hutan |
Author_xml | – sequence: 1 givenname: Aruchuna surname: Ruban fullname: Ruban, Aruchuna organization: University Hospital Southampton, Southampton, UK – sequence: 2 givenname: Michael surname: Glaysher fullname: Glaysher, Michael organization: University Hospital Southampton, Southampton, UK – sequence: 3 givenname: Alexander surname: Miras fullname: Miras, Alexander organization: University Hospital Southampton, Southampton, UK – sequence: 4 givenname: Christina surname: Prechtl fullname: Prechtl, Christina organization: University Hospital Southampton, Southampton, UK – sequence: 5 givenname: Anthony surname: Goldstone fullname: Goldstone, Anthony organization: University Hospital Southampton, Southampton, UK – sequence: 6 givenname: Madhawi surname: Aldhwayan fullname: Aldhwayan, Madhawi organization: University Hospital Southampton, Southampton, UK – sequence: 7 givenname: Navpreet surname: Chhina fullname: Chhina, Navpreet organization: University Hospital Southampton, Southampton, UK – sequence: 8 givenname: Werd surname: Al-Najim fullname: Al-Najim, Werd organization: University Hospital Southampton, Southampton, UK – sequence: 9 givenname: Hutan surname: Ashrafian fullname: Ashrafian, Hutan organization: University Hospital Southampton, Southampton, UK – sequence: 10 givenname: James surname: Byrne fullname: Byrne, James organization: University Hospital Southampton, Southampton, UK – sequence: 11 givenname: Julian surname: Teare fullname: Teare, Julian organization: University Hospital Southampton, Southampton, UK |
BookMark | eNo9kM1KAzEUhYNUsK2-Q8SNLlJzk5lJxp0U_6CgUPchyWTqDPNnMrPozo0v6pOYUnF14N7Dge9boFnXdw6hS6ArAJ7d7qax7hrCKKPEhJ3V7TCFFWdwguaQZJJwJuUMzSkFQVKR5GdoEUJNKZUyhzka3lgifr6-t7p04x4Pvi-rxuG-xOOHw8XUF67TDaldPcXEZj_oEHBTdc7ja9cVvdHeV87f3GGN26kZK-u60TvsdXy2VXAFtn289A0efaWbc3Ra6ia4i79cou3jw_v6mWxen17W9xtigCVAmLRCS5ZRbgznUktd5lKANVBkNtWQOJEJbk3qUshZmkMKNjEJUF2UVvAlujquRqDPyYVR1f3kI0FQkTfPOHBOYys5tkxbq8FXrfZ7BVQdzKqjWXUwq_7NqmiW_wI5p3Th |
ContentType | Journal Article |
Copyright | Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. 2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. |
Copyright_xml | – notice: Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. |
DBID | 3V. 7X7 7XB 88E 88I 8AF 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI BTHHO CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PQEST PQQKQ PQUKI PRINS Q9U |
DOI | 10.1136/gutjnl-2020-bsgcampus.321 |
DatabaseName | ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection BMJ Journals ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Science Database Biological Science Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic |
DatabaseTitle | ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition BMJ Journals ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | ProQuest Central Student |
Database_xml | – sequence: 1 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1468-3288 |
EndPage | A170 |
GroupedDBID | --- .55 .GJ .VT 08G 0R~ 18M 29I 2WC 354 39C 3O- 3V. 4.4 40O 53G 5GY 5VS 7X7 7~S 88E 88I 8AF 8F7 8FE 8FH 8FI 8FJ 8R4 8R5 AAHLL AAKAS AAOJX AAUVZ AAWJN AAYEP ABAAH ABJNI ABKDF ABMQD ABOCM ABTFR ABUWG ABVAJ ACGFO ACGFS ACGOD ACGTL ACHTP ACMFJ ACOFX ACTZY ADBBV ADCEG ADFRT ADUGQ ADZCM AENEX AFKRA AFWFF AHMBA AHNKE AHQMW AI. AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C1A C45 CAG CCPQU COF CS3 CXRWF DIK DU5 DWQXO E3Z EBS EJD F5P FD8 FEDTE FYUFA GNUQQ GX1 H13 HAJ HCIFZ HMCUK HVGLF HYE HZ~ IAO IEA IH2 IHR INH INR IOF ITC J5H KQ8 L7B LK8 M1P M2P M7P N9A NTWIH NXWIF O9- OK1 OVD P2P PQQKQ PROAC PSQYO Q2X R53 RHF RHI RMJ RPM RV8 TEORI TR2 UKHRP UYXKK V24 VH1 VM9 VVN W8F WH7 WOQ X7M YFH YOC YQY ZGI ZXP ZY1 7XB 8FK K9. PQEST PQUKI PRINS Q9U |
ID | FETCH-LOGICAL-b1241-28c7a82603bb338a8af9871cb1d6c5a14e7673cb5e519259151c4b410adfc73 |
IEDL.DBID | BENPR |
ISSN | 0017-5749 |
IngestDate | Thu Oct 10 17:00:43 EDT 2024 Wed Aug 21 03:32:09 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Suppl 1 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b1241-28c7a82603bb338a8af9871cb1d6c5a14e7673cb5e519259151c4b410adfc73 |
OpenAccessLink | https://gut.bmj.com/content/gutjnl/70/Suppl_1/A170.1.full.pdf |
PQID | 2479631330 |
PQPubID | 2041069 |
ParticipantIDs | proquest_journals_2479631330 bmj_primary_10_1136_gutjnl_2020_bsgcampus_321 |
PublicationCentury | 2000 |
PublicationDate | 20210100 20210101 |
PublicationDateYYYYMMDD | 2021-01-01 |
PublicationDate_xml | – month: 01 year: 2021 text: 20210100 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | Gut |
PublicationYear | 2021 |
Publisher | BMJ Publishing Group LTD |
Publisher_xml | – name: BMJ Publishing Group LTD |
SSID | ssj0008891 |
Score | 2.3977587 |
Snippet | IntroductionThe Endobarrier is an endoluminal duodenal-jejunal bypass liner (DJBL) developed by GI Dynamics for the treatment of obese patients with T2DM. It... |
SourceID | proquest bmj |
SourceType | Aggregation Database Publisher |
StartPage | A170 |
SubjectTerms | Abscesses Antibiotics Cholecystitis Cholestasis Clinical trials Complications Diabetes mellitus (non-insulin dependent) Explants Gastric bypass Gastrointestinal surgery Liver Pain Patients Surgery Transplants & implants |
Title | P247 Safety profile of the duodenal-jejunal bypass liner (endobarrier): a multicentre randomised control trial |
URI | http://dx.doi.org/10.1136/gutjnl-2020-bsgcampus.321 https://www.proquest.com/docview/2479631330 |
Volume | 70 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEF5sC-JFfOKjygoe9LCaZJPd1IuoWIrQIj6gt7CvFEqbxKY5ePPiH_WXOJtu9SB4DixhZnfm-2aG-RA6pbHiXANyS2nMSMhSjwgRceJTA9ke8AWrt_P3B6z3Gj4Mo6EruJVurHIZE-tArXNla-SXQcjhrgCj8q6LN2JVo2x31UloNFAr8EPbpm3d3g8en35icbzUzINYHPGws4pOnI7J5aiaj7MJ3BLgT7IcKTEtqvKC2qWhDTkd_4nNdcLpbqB1hxTxzcK1m2jFZFtote964duoeISf_fr4fBapmb9jJ76N8xQDpsO6yiGiiAkZm3Flz5HvBeBkbFHlDJ-ZTMNDnlm5uvMrLHA9V1gPahoM2Uvn4H6jsRtkx7W2xw567t6_3PWI008gErK2TwLwgwD64FEpgYmKWKQd4EdK-pqpSPih4YxTJSMDMA5oECR_FcrQ94ROFae7qJnlmdlD2EQKgARTgaCWw3qCaW232pjABJSmbB8RsFhSLPZjJDWvoCxZWDixFk5-LJyAhfdRe2nbxD2ZMvl18MH_nw_RWmAHS-o6SBs157PKHAEymMtj1OBDfuwuwTe3v7n8 |
link.rule.ids | 315,786,790,12083,21416,27955,27956,31752,33777,43343,43838,74100,74657 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NTxsxELX4kIALggIiBYor9VAOLrtrrx24oKoqCjSJKgFSbpa_NlKU7G6T7CE3Lv2j_SWMHYcekDivZK1mxjPvjUfzEPpC20YIC8itoG1OGC8SolQuSEodVHvAFzxs5-_1eeeJ3Q_yQWy4zeJY5SonhkRtK-N75JcZExArwKiSm_oP8apR_nU1Smiso01GKfNxLgavhMtP8KSrTJwLdrWFPkcVk8thMx-VY4gRYE96NjRqUjezb9SvDF3Xk9GbzBzKze0e2o04EX9fOnYfrbnyA9rqxZfwA1T_hl_99_z3QRVuvsBRehtXBQZEh21TQT5RYzJyo8afoxc1oGTsMeUUf3WlhWs89WJ1F9dY4TBVGMY0HYbaZStwvrM4jrHjoOxxiB5ufz7-6JConkA01OyUZOAFBeQhoVoDD1VtVVwBOzI6tdzkKmVOcEGNzh2AOCBBUPoN0yxNlC2MoEdoo6xKd4ywyw3ACG4yRT2DTRS31u-0cZnLKC14CxGwmKyX2zFkYBWUy6WFpbewfLWwBAu30OnKtjJemJn8796P738-R9udx15Xdu_6v07QTuZHTEJH5BRtzKeNOwOMMNefQiC8AAeDupw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3LSgMxFA0-oLgRn_ioGsGFLmJnJjNJ60ZELb4RVOgu5DVC0Zmx7SzcufFH_RJv0lQXguuBMNzc3HtOcrgHoT3a1pwbQG45bTOSsjwiUmacxNRCtwd8wfx0_ts7dvGUXvWyXtA_DYOsclITfaE2pXZ35K0k5ZArwKiiVh5kEfdn3ePqjTgHKffSGuw0ptEsdMnI2Tjw3g_5cmqeeFKVM552Gmg3OJq0nutRv3iBfAEmpYbPWr5W9fCQuvGh0-q1_6dK-9bTXUDzATPik_EmL6IpWyyhxm14FV9G1T389tfH54PM7egdBxtuXOYY0B02dQm1Rb6Qvu3Xbh31XgFixg5fDvC-LQwc6YEzrjs4whJ7haGXbFoMfcyUkAjW4CBpx97lYwU9dM8fTy9IcFIgCvp3TBLYEQlEIqJKASeVbZl3gClpFRumMxmnljNOtcosADogRAADdKogitLkmtNVNFOUhV1D2GYaIAXTiaSOzUaSGePm29jEJpTmbB0RiJioxpMyhGcYlIlxhIWLsPiJsIAIr6PmJLYiHJ6h-N3qjf8_76AG5IC4uby73kRziVOb-MuRJpoZDWq7BXBhpLZ9HnwDb-S-yA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=P247%E2%80%85Safety+profile+of+the+duodenal-jejunal+bypass+liner+%28endobarrier%29%3A+a+multicentre+randomised+control+trial&rft.jtitle=Gut&rft.au=Ruban%2C+Aruchuna&rft.au=Glaysher%2C+Michael&rft.au=Miras%2C+Alexander&rft.au=Prechtl%2C+Christina&rft.date=2021-01-01&rft.pub=BMJ+Publishing+Group+LTD&rft.issn=0017-5749&rft.eissn=1468-3288&rft.volume=70&rft.issue=Suppl+1&rft.spage=A170&rft.epage=A170&rft_id=info:doi/10.1136%2Fgutjnl-2020-bsgcampus.321&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0017-5749&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0017-5749&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0017-5749&client=summon |